One scientific breakthrough can change countless lives
In pursuit of the impossible
Watch the film
We believe in helping people who are struggling
with serious and debilitating diseases.
SCIENCE
Delivering on
unmet needs
unmet needs
Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses.
Learn about our workAMYOTROPHIC LATERAL SCLEROSIS
Our relentless commitment
Many people living with amyotrophic lateral
sclerosis (ALS) have unmet medical needs.
We are committed to doing our best to find
solutions that may help address those needs.
News
Important news about our latest
developments in science & medicine.
PRESS RELEASES
- RADICAVA ORS® (edaravone) Now Available in the U.S. for the Treatment of ALS Read More Jun 15, 2022
- Mitsubishi Tanabe Pharma America Presents 48-Week Results from Global Phase 3 Safety Clinical Study of RADICAVA ORS® (edaravone), an Oral Treatment for ALS Read More Jun 01, 2022
- Mitsubishi Tanabe Pharma America Announces FDA Approval of RADICAVA ORS® (edaravone) for the Treatment of ALS Read More May 12, 2022